| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |